Newsroom

TORONTO--(BUSINESS WIRE)--Dream Industrial Real Estate Investment Trust (DIR.UN-TSX) or (the “REIT” or “Trust” or “Dream Industrial REIT” or “DIR” or “we” or “us”) today announced its financial results for the three and six months ended June 30, 2026. Management will host a conference call to discuss the financial results on August 5, 2026 at 11:00 a.m. (ET). “Dream Industrial delivered another consecutive quarter of strong results, with over 10% comparative properties NOI growth and 8% FFO per...

CINCINNATI--(BUSINESS WIRE)--ProAmpac, ein weltweit führendes Unternehmen im Bereich flexibler Verpackungen und Materialwissenschaften, gibt die Veröffentlichung seines 2026 Sustainability Impact Report bekannt. Unter dem Leitmotiv Growing with Purpose, Delivering with Impact beleuchtet der Bericht die Fortschritte des Unternehmens in den Bereichen nachhaltige Innovation, Umweltschutz, Arbeitssicherheit und verantwortungsbewusste Geschäftspraktiken bei gleichzeitiger Ausweitung seiner globalen...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Orion Digital Corp. (NASDAQ: ORIO; TSX: ORIO) (“Orion Digital” or the “Company”) today announced it will hold a conference call and webcast to discuss its Q2 2026 financial results on Thursday, August 6, 2026 at 11:00 a.m. ET. The call will be hosted by David Feller, Orion Digital's Founder & CEO, and Greg Feller, President & CFO. The Company will issue its financial results prior to market open on August 6. CONFERENCE CALL DETAILS: DATE: Th...

LAVAL, Québec--(BUSINESS WIRE)--Altasciences deelt met genoegen mee dat het zijn R&D-laboratorium heeft uitgebreid als zijn faciliteit voor formules van geneesmiddelproducten en productiediensten in Harleysville, Pennsylvanië, met een toevoeging van circa 768 vierkante voet nieuwe laboratoriumruimte. De uitbreiding brengt de ontwikkeling van formules en analytische testen in één enkel laboratorium samen. Deze geïntegreerde configuratie is bedoeld om het nemen van beslissingen te versnellen,...

LAS VEGAS--(BUSINESS WIRE)--Light & Wonder, Inc. (ASX: LNW) (“Light & Wonder,” “L&W,” “we” or the “Company”) today reported results for the second quarter ended June 30, 2026. Light & Wonder delivered another quarter of consolidated earnings growth and margin expansion across all business segments, underpinned by its highly diversified business model and disciplined capital allocation, with continued strong cash flow generation and momentum expected to build into the second half...

سان فرانسيسكو وتل أبيب، إسرائيل--(BUSINESS WIRE)--اليوم، أعلنت Visa (رمزها في بورصة نيويورك: V) عن توقيعها اتفاقية نهائية للاستحواذ على BioCatch، وهي شركة رائدة في مجال توفير معلومات الاحتيال متعددة الإشارات والقائمة على السلوك، من صناديق تديرها شركة Permira ومساهمون آخرون مقابل 2.4 مليار دولار نقدًا. وتسير عملية الاستحواذ على BioCatch على نهج حلول Visa الحالية في مجال الأمن السيبراني والاحتيال والمخاطر والأمن، ومن المتوقع أن تساعد العملاء في حماية أنفسهم وعملائهم بشكل أفضل من التهديد المتزايد ل...

LAVAL, Quebec--(BUSINESS WIRE)--Altasciences è entusiasta di annunciare l'ampliamento del laboratorio di R&S presso il proprio impianto di produzione e formulazione di prodotti di Harleysville, Pennsylvania, aggiungendo una nuova superficie di circa 768 piedi quadrati dedicata al laboratorio. L'espansione riunisce in un unico laboratorio lo sviluppo della formulazione e i test analitici dei prodotti. Questa configurazione integrata è progettata per accelerare il processo decisionale, sempli...

PLYMOUTH TOWNSHIP, Pa.--(BUSINESS WIRE)--New analysis shows that blocking Plymouth Twp. data center will cost $424 million in lost tax revenue and 15,000 high-paying construction jobs...

LAVAL, Québec--(BUSINESS WIRE)--Altasciences a le plaisir d’annoncer l’agrandissement de son laboratoire de R&D sur son site de Harleysville, en Pennsylvanie, dédié aux services de formulation et de fabrication de médicaments, avec l’ajout d’environ 768 pieds carrés d’espaces de laboratoire supplémentaires. Cet agrandissement permet de regrouper les fonctions de développement des formulations et d’analyse au sein d’un même laboratoire. Cette configuration intégrée vise à accélérer la prise...

聖地牙哥--(BUSINESS WIRE)--(美國商業資訊)-- Invivoscribe®旗下子公司LabPMM®今日宣布，其全新的KMT2A微小殘留病灶(MRD)檢測服務現已在全球推出。這項高靈敏度的數位PCR服務透過LabPMM的全球實驗室網路向醫療保健提供者、臨床研究人員和生物製藥合作夥伴開放，其中經過CAP/CLIA認證的檢測服務將在美國地區提供。該服務旨在滿足對於急性白血病精準分子監測與日俱增的需求。1,2,3 KMT2A重排(KMT2A r)是急性髓系白血病(AML)和急性淋巴細胞白血病(ALL)中的致癌驅動因素。4這類重排存在於約80%的嬰兒白血病病例以及5-15%的兒童和成人白血病病例中。5攜帶KMT2A重排的白血病通常與化療抗藥、高復發率和較差的臨床預後相關。5 Menin抑制劑的出現正在改變AML和ALL病患的治療格局，特別是對於攜帶KMT2A重排和NPM1突變的病患。6首款獲得FDA核准用於治療攜帶KMT2A易位的復發或難治性急性白血病的Menin抑制劑，確立了這一新興藥物類別的臨床價值。7隨著Menin抑制劑計畫向一線治療和聯合療法研究推進，臨床日益需要高靈...